ClinicalTrials.gg
CompletedNCT00520039OOMRSUpdated Mar 26, 2018Results posted

Osteopathic Otitis Media Research Study

An interventional study of osteopathic manipulative medicine (OMM) in Otitis Media With Effusion, sponsored by West Virginia School of Osteopathic Medicine. Completed at 2 sites in United States. Open to participants aged 6 Months to 2 Years. Per ClinicalTrials.gov, last updated 2018-03-26.

Sponsored by West Virginia School of Osteopathic Medicine · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
6 Months to 2 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Otitis Media with Effusion with a site in United States — 7 open to participants now, 8 under way, none of them phase 3. Otitis Media with Effusion · United States.

Enrollment
13th of 20
52 · median 82
Started
2007
with 1 other
No phase
10 of 27
5 open now
Registered
5th of 27
by date

Among the 27 studies in Otitis Media with Effusion with a site in United States, this one is the 13th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2007, is one of 10 with no phase, and was the 5th registered.

Otitis Media with Effusion

88 studies on the registry are indexed under Otitis Media with Effusion; 17 are open to participants now.

Browse Otitis Media with Effusion studies →

Open to participants now

7 of the 27 studies in Otitis Media with Effusion with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 8 Otitis Media with Effusion studies recruiting now, 1 sets no upper age limit and 7 stop at 75 or younger; 8 take children under 18; 2 take healthy volunteers.

This study: 6 Months to 2 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Otitis Media with Effusion with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to determine if the application of osteopathic manipulative medicine speeds the rate of resolution of middle ear effusion (fluid) in children following an episode of acute otitis media.

Read the detailed description

Acute otitis media is a significant world wide problem commonly affecting children between 6 and 18 months, and is the most frequent reason for childhood illness visits to a physician in the US. By three years of age, 50-70% of children will have had one episode, while one-third will have had more than three. Persistence of middle ear effusion following an episode of acute otitis media is thought to predispose the child to recurrent infection. The standard care for recurrent acute otitis media includes long term antibiotic prophylaxis and surgery. The risks of standard care are recognized, and alternative means of treating acute disease and preventing recurrent otitis media are needed.

For over a century, osteopathic physicians have reported favorable clinical outcomes in children treated with osteopathic manipulative medicine (OMM) in addition to standard medical care. To determine if a standardized OMM protocol will reduce the duration of middle ear effusion (MEE) after onset of acute otitis media, we outline a prospective, randomized, blinded, multi-center efficacy study of children ages six months to two years with a single episode of acute otitis media. Subjects will be randomized into one of two treatment groups: standard care plus OMM and standard care only. Subjects will be followed for one month to determine rate of resolution of middle ear effusion following onset of the acute otitis media. Statistical analysis will determine any differences between subjects in the two treatment groups.

03

Conditions studied

  • Otitis Media With Effusion

Keywords

  • Otitis Media
  • Effusion
  • OMM
  • OMT
  • Resolution
04

Who can participate

Ages eligible
6 Months to 2 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 6 months up to second birthday
  • Documented presence of acute otitis media following the 2004 AAP/AAFP Guidelines within 3 days of entry into the study

Exclusion criteria

Exclusion Criteria:

  • Chromosomal abnormalities
  • Major congenital malformations of the head and neck, including torticollis
  • Immunologic abnormalities or deficiencies
  • Any prior ear-nose-throat surgery performed as a treatment for otitis media
  • Any tube placement surgery scheduled during the four weeks of the study.
  • Normal tympanograms at entry into study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Standard Care Plus OMM

    Subjects will receive active intervention with osteopathic manipulative medicine (OMM) using a prescribed standardized treatment protocol which is age appropriate. Subjects will also receive standard care for otitis media from their referring physician.

    Procedure: osteopathic manipulative medicine (OMM)

  • No intervention
    Standard Care Only

    Subjects will receive standard care only for otitis media from their regular referring physician

Interventions

  • Procedureosteopathic manipulative medicine (OMM)

    At each of the first three study visits, all subjects in the osteopathic manipulative medicine (OMM) group will receive OMM using the prescribed protocol.

06

What researchers measure

Primary outcomes

  1. Change in Middle Ear Effusion Over Four Weeks Following an Episode of Acute Otitis Media

    For this study, the tympanogram was chosen to measure middle ear effusion. Three tympanogram readings from each ear included in the study were taken at the beginning of each of 5 Study Visits. For the intervention group, a second set of 3 tympanograms was taken immediately after the OMM on Visits 1, 2 and 3. All tympanograms were sent to a blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed from baseline over 4 weeks was computed by crosstabulating the intervention group by the normal/abnormal changes in tympanograms.

    Time frame: 1 month

Secondary outcomes

  1. Change in Middle Ear Effusion Immediately After OMM at Study Visit 2

    For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 2, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.

    Time frame: Before and immediately after OMM at study visit 2

  2. Change in Middle Ear Effusion Immediately After OMM at Study Visit 3

    For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 3, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.

    Time frame: Before and immediately after OMM at study visit 3

07

Results

Posted Mar 26, 2018
Limitations and caveats
One site closed after year 1 due to lower than expected subject recruitment. Lower than expected recruitment overall.

Participant flow

Recruitment dates: September 2007 through May 2009 Site: medical clinics of 2 colleges of osteopathic medicine Location: mid-Atlantic and Northeast areas of the United States

Participant flow — Overall Study
MilestoneStandard Care Plus OMM (SC+OMM)Standard Care Only (SCO)
Started2824
Completed2119
Not completed75
Withdrew: Exclusion criteria met at first visit75

Outcome measures

PrimaryChange in Middle Ear Effusion Over Four Weeks Following an Episode of Acute Otitis Media

For this study, the tympanogram was chosen to measure middle ear effusion. Three tympanogram readings from each ear included in the study were taken at the beginning of each of 5 Study Visits. For the intervention group, a second set of 3 tympanograms was taken immediately after the OMM on Visits 1, 2 and 3. All tympanograms were sent to a blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed from baseline over 4 weeks was computed by crosstabulating the intervention group by the normal/abnormal changes in tympanograms.

Time frame:
1 month
Reported as:
Number · Ears
Change in Middle Ear Effusion Over Four Weeks Following an Episode of Acute Otitis Media
EarsStandard Care Plus OMM (SC+OMM)Standard Care Only (SCO)
Improvement in MEE at 2 weeks2616
No Improvement in MEE at 2 weeks1222
Statistical analysis
  • Standard Care Plus OMM (SC+OMM) vs Standard Care Only (SCO) · Chi-squared · p = 0.02 · Odds ratio, log: 1.09 · 95% CI 0.15 to 2.03The denominator of the Odds ratio represents the odds of improvement for the Standard Care Only (SCO) group.
SecondaryChange in Middle Ear Effusion Immediately After OMM at Study Visit 2

For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 2, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.

Time frame:
Before and immediately after OMM at study visit 2
Reported as:
Number · ears
Change in Middle Ear Effusion Immediately After OMM at Study Visit 2
earsBefore OMMAfter OMM
Resolution of MEE after OMM at Visit 256
No Resolution of MEE at end of OMM at visit 22623
Statistical analysis
  • Before OMM vs After OMM · Chi-squared · p = 0.32 · Odds ratio, log: 0.31 · 95% CI -1.00 to 1.62The odds of Resolution of MEE before OMT is represented in the denominator of the odds ratio
SecondaryChange in Middle Ear Effusion Immediately After OMM at Study Visit 3

For this study, the tympanogram was chosen to measure middle ear effusion. For the SC+OMT Group during study visit 3, three tympanogram readings from each ear included in the study were taken prior to, and immediately after the intervention. The tympanograms were sent to the blinded audiologist, who chose the most healthy of the 3 tympanogram readings for interpretation, rating it according to standard protocols. "A" and "C1" readings were considered "normal" and "B" and "C2" readings were considered "abnormal". The extent to which the tympanogram readings of each ear included in the study changed between "normal" and "abnormal" from before and after the OMM was computed.

Time frame:
Before and immediately after OMM at study visit 3
Reported as:
Number · ears
Change in Middle Ear Effusion Immediately After OMM at Study Visit 3
earsBefore OMMAfter OMM
Resolution of MEE at Visit 31213
No Resolution of MEE after OMM at Visit 31925
Statistical analysis
  • Before OMM vs After OMM · Chi-squared · p = .31 · Odds ratio, log: 0.25 · 95% CI -0.78 to 1.28df = 1

Adverse events

Collected over 1month. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard Care Plus OMM—0/28 (0%)0/28 (0%)
Standard Care Only—0/24 (0%)0/24 (0%)

Baseline characteristics

52 participants were enrolled and 12 excluded due to normal tympanograms at first study visit, leaving 19 subjects in the SCO and 21 subjects in the SC+OMM group.

Age, Categorical
Age, Categorical(Participants)Standard Care Plus OMMStandard Care OnlyTotal
<=18 years282452
Between 18 and 65 years000
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Standard Care Plus OMMStandard Care OnlyTotal
Female121123
Male161329
Region of Enrollment
Region of Enrollment(participants)Standard Care Plus OMMStandard Care OnlyTotal
United States282452
08

Study locations

2 sites
  • University of New England College of Osteopathic Medicine
    Biddeford, Maine 04005, United States
  • West Virginia School of Osteopathic Medicine
    Lewisburg, West Virginia 24901, United States
09

References and documents

Publications

  • Steele KM, Carreiro JE, Viola JH, Conte JA, Ridpath LC. Effect of osteopathic manipulative treatment on middle ear effusion following acute otitis media in young children: a pilot study. J Am Osteopath Assoc. 2014 Jun;114(6):436-47. doi: 10.7556/jaoa.2014.094. PubMed 24917631 ↗
  • Steele KM, Viola J, Burns E, Carreiro JE. Brief report of a clinical trial on the duration of middle ear effusion in young children using a standardized osteopathic manipulative medicine protocol. J Am Osteopath Assoc. 2010 May;110(5):278-84. PubMed 20538749 ↗

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2007, a primary completion of Aug 2009 and a completion of Aug 2009. It does not say whether these dates are actual or estimated.

Results were first posted in Mar 2018, 8 years 7 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2007
First posted
Aug 23, 2007
Start
Sep 2007
Primary completionActual
Aug 2009
CompletionActual
Aug 2009
Results first posted
Mar 26, 2018
Last update
Mar 26, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00520039
Lead sponsor
West Virginia School of Osteopathic Medicine
Collaborators
University of New England, American Academy of Osteopathy, Osteopathic Research Center
Responsible party
Karen M. Steele, D.O., FAAO (Professor Emerita, West Virginia School of Osteopathic Medicine) — Principal investigator
First posted
Aug 23, 2007
Start date
Sep 2007
Primary completion
Aug 2009
Completion
Aug 2009
Results posted
Mar 26, 2018
Last update
Mar 26, 2018

Study contacts

Karen M Steele, D.O.
principal investigator · West Virginia School of Osteopathic Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion